Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Cross-Reactivity of Drug-Dependent Antibodies in Patients with Immune Thrombocytopenia Induced By Beta-Lactam Antibiotics

Matthew John Slaught, BS, Daniel W. Bougie, PhD, Richard H. Aster, MD

Blood (2019) 134 (Supplement_1): 2350.

https://doi.org/10.1182/blood-2019-131375

Published: 2019

Journal Articles

Treatment of Elderly and Unfit AML Patients with Prolonged Administration of Low Dose Cytarabine and Thioguanine Achieves High Complete Remission Rates in an Outpatient Setting

Christopher K Arthur, Anthony Jeffrey, Molly Forbes, Eva Yip, Vicki Katsioulas, William S. Stevenson, MBBS, PhD

Blood (2018) 132 (Supplement 1): 3998.

https://doi.org/10.1182/blood-2018-99-118027

Published: 2018

Journal Articles

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Bruno K L Duarte, Gabriela G Yamaguti Hayakawa, MD, Francisco A Ferreira, MD, Katia B B Pagnano, MD PhD, Erich Vinicius De Paula, MD PhD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 4651.

https://doi.org/10.1182/blood.V130.Suppl_1.4651.4651

Published: 2017

Journal Articles

Dentist to Oncologist: Gingival Hyperplasia in AML Accompanied By Periodontal Infection- Case Report

Abdulraheem Yacoub, MD, Gauranga Mahalwar

Blood (2016) 128 (22): 5187.

https://doi.org/10.1182/blood.V128.22.5187.5187

Published: 2016

Journal Articles

Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting

Nathan P Clark, PharmD, FCCP, BCPS, Thomas Delate, PhD, MS, Catherine S Riggs, PharmD, Daniel M Witt, PharmD, FCCP, BCPS, Elaine M Hylek, MD, David A Garcia, MD, Walter Ageno, MD, Francesco Dentali, MD, Mark A. Crowther, MD, MSc, FRCPC

Blood (2013) 122 (21): 1143.

https://doi.org/10.1182/blood.V122.21.1143.1143

Published: 2013

Journal Articles

Efficacy Of Helicobacter Pylori Eradication For The First Line Treatment Of Immune Thrombocytopenia Patients With Moderate Thrombocytopenia

Hyo Jung Kim, M.D., Won Sik Lee, M.D., Hawk Kim, M.D., Jung-Hee Lee, M.D., Sang Min Lee, M.D., Sung Hwa Bae, M.D., Myung Soo Hyun, M.D., Je-Hwan Lee, M.D.

Blood (2013) 122 (21): 2324.

https://doi.org/10.1182/blood.V122.21.2324.2324

Published: 2013

Journal Articles

Fluoroquinolone Prophylaxis Following Induction Chemotherapy in Patients with Acute Leukemia: Patterns of Infection

Patrick Reagan, MD, Tri Le, MD, Michael E. Williams, M.D., Nolan Wages, PhD

Blood (2012) 120 (21): 2077.

https://doi.org/10.1182/blood.V120.21.2077.2077

Published: 2012

Journal Articles

Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study

M Domenica Cappellini, MD, Amal El-Beshlawy, MD, John B Porter, MD, Antonis Kattamis, MD, PhD, Kerry Taylor, MD, Christian Rose, Vernon J Louw, MD, Ali El-Ali, MD, Nicolas Martin, MS, Norbert Gattermann, MD

Blood (2012) 120 (21): 5182.

https://doi.org/10.1182/blood.V120.21.5182.5182

Published: 2012

Journal Articles

An Evaluation of Septicemia During Outpatient Consolidation Chemotherapy for Acute Myeloid Leukemia

Lalit Saini, MD, Mark D. Minden, MD, PhD, Andre Schuh, MD, Karen Yee, MD, Aaron D Schimmer, MD, PhD, Vikas Gupta, MD, FRCP, FRCPath, Cindy Susan Murray, Joseph Brandwein, MD

Blood (2011) 118 (21): 4268.

https://doi.org/10.1182/blood.V118.21.4268.4268

Published: 2011

Journal Articles

The Efficacy of H. pylori Eradication Therapy in H. pylori -Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.

Donald M. Arnold, MD, Ashley Bernotas, Ishac Nazi, PhD, Roberto Stasi, MD, Masataka Kuwana, MD, PhD, John G. Kelton, MD, FRCPC, Mark A. Crowther, MD

Blood (2008) 112 (11): 3413.

https://doi.org/10.1182/blood.V112.11.3413.3413

Published: 2008

Journal Articles

Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Patients with High-Risk AML in First CR: The ALFA-0702 Pilot Study.

Xavier Thomas, Ida Lobe, Emmanuel Raffoux, Nicolas Boissel, Quoc-Hung Le, Franck Nicolini, Adrienne de Labarthe, Sandrine Hayette, Jean-Michel Cayuela, Hervé Dombret

Blood (2008) 112 (11): 1934.

https://doi.org/10.1182/blood.V112.11.1934.1934

Published: 2008

Journal Articles

Long Term Outcome of Gastric MALT Lymphoma Patients Treated with Anti-Helicobacter (Antibiotic and Proton-Pump Inhibitor) Regimens.

Claudio Chini, MD, Graziella Pinotti, MD, Anastasios Stathis, MD, Ilaria Proserpio, MD, Francesco Bertoni, MD, Franco Cavalli, MD, Emanuele Zucca, MD

Blood (2007) 110 (11): 2583.

https://doi.org/10.1182/blood.V110.11.2583.2583

Published: 2007

Journal Articles

Feasibility and Safety Profile of Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Younger Patients with AML in First Complete Remission (AML-CR1).

Ida Lobe, Nicolas Boissel, Emmanuel Raffoux, Adrienne de Labarthe, Cécile Pautas, Stéphane de Botton, Xavier Thomas, Hervé Dombret

Blood (2007) 110 (11): 1853.

https://doi.org/10.1182/blood.V110.11.1853.1853

Published: 2007

Journal Articles

Eradication of Helicobacter pylori Shifts the Balance of Fcγ Receptors on Monocytes toward the Inhibitory FcγRIIB in Patients with Chronic ITP.

Masataka Kuwana, MD, PhD, Atsuko Asahi, MD, Hidekazu Suzuki, MD, PhD, Yuka Okazaki, Yasuo Ikeda, MD

Blood (2006) 108 (11): 1082.

https://doi.org/10.1182/blood.V108.11.1082.1082

Published: 2006

Journal Articles

Helicobater Pylori Infection and Clinical Response to Eradication Therapy in Patients with Immune Thrombocytopenic Purpura (ITP).

Fabrizio Fabris, MD, Emanuele Allemand, MD, Raffaella Scandellari, MD, Silvia Vettore, PhD, Maria Luigia Randi, MD, Guido Luzzatto, MD

Blood (2005) 106 (11): 3996.

https://doi.org/10.1182/blood.V106.11.3996.3996

Published: 2005

Journal Articles

The Clinical Efficacy of Helicobacter pylori Eradication in Patients with Helicobacter pylori -Positive Chronic Thrombocytopenic Purpura.

Seung-Hyun Nam, MD, Bong-Seog Kim, MD, Jae Hoon Lee, MD, Hong Suk Song, MD, Sung-Hwa Bae, MD, Myung Soo Hyun, MD, Young Jin Yuh, MD, Sang-Jae Lee, MD, Seonyang Park, MD

Blood (2005) 106 (11): 4002.

https://doi.org/10.1182/blood.V106.11.4002.4002

Published: 2005

Journal Articles

Pegylated Liposomal Doxorubicin (Doxil ® ), Dexamethasone and Low Dose Thalidomide (DDt) as Therapy for Newly Diagnosed Multiple Myeloma.

Delva Deauna-Limayo, MD, Omar S. Aljitawi, MD, Mathew Mayo, PhD, David C. Bodensteiner, MD, Siddhartha Ganguly, MD, Barry S. Skikne, MD, Kambhampati Suman, MD

Blood (2005) 106 (11): 5164.

https://doi.org/10.1182/blood.V106.11.5164.5164

Published: 2005

Journal Articles

Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) Results in a High Response Rate in Patients with Refractory Multiple Myeloma (RMM).

Rachid Baz, MD, Toni K. Choueiri, MD, Rony Abou Jawde, MD, Bridget McGowan, Yvette Ellis, Catherine Brand, Mohamad A. Hussein, MD

Blood (2005) 106 (11): 2559.

https://doi.org/10.1182/blood.V106.11.2559.2559

Published: 2005

Journal Articles

Therapeutic Action of Helicobacter pylori ( H. pylori ) Eradication in Patients with Chronic ITP - Lessons from Eradication Therapy on H. pylori -Negative Patients.

Atsuko Asahi, MD, Masataka Kuwana, MD, Hidekazu Suzuki, MD, Yuka Okazaki, Tatehiro Masaoka, MD, Yasuo Ikeda, MD

Blood (2004) 104 (11): 2070.

https://doi.org/10.1182/blood.V104.11.2070.2070

Published: 2004

Journal Articles

Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) a Phase I/II Trial in Advanced Relapsed/Refractory Multiple Myeloma (RMM) Patients.

Mohamad A. Hussein, MD, Mary Ann Karam, RN, Catherine Brand, Greg L. Pearce, Janice Reed, RN, Kellie Bruening, Paul Sartori, Gordan Srkalovic, MD, PhD, Marta Olesnyckyj, RN, Robert Knight, MD, Kathe Balinski, RN, MA, Jerome Zeldis, MD, PhD

Blood (2004) 104 (11): 208.

https://doi.org/10.1182/blood.V104.11.208.208

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Cross-Reactivity of Drug-Dependent Antibodies in Patients with Immune Thrombocytopenia Induced By Beta-Lactam Antibiotics

Treatment of Elderly and Unfit AML Patients with Prolonged Administration of Low Dose Cytarabine and Thioguanine Achieves High Complete Remission Rates in an Outpatient Setting

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Dentist to Oncologist: Gingival Hyperplasia in AML Accompanied By Periodontal Infection- Case Report

Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting

Efficacy Of Helicobacter Pylori Eradication For The First Line Treatment Of Immune Thrombocytopenia Patients With Moderate Thrombocytopenia

Fluoroquinolone Prophylaxis Following Induction Chemotherapy in Patients with Acute Leukemia: Patterns of Infection

Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study

An Evaluation of Septicemia During Outpatient Consolidation Chemotherapy for Acute Myeloid Leukemia

The Efficacy of H. pylori Eradication Therapy in H. pylori -Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.

Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Patients with High-Risk AML in First CR: The ALFA-0702 Pilot Study.

Long Term Outcome of Gastric MALT Lymphoma Patients Treated with Anti-Helicobacter (Antibiotic and Proton-Pump Inhibitor) Regimens.

Feasibility and Safety Profile of Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Younger Patients with AML in First Complete Remission (AML-CR1).

Eradication of Helicobacter pylori Shifts the Balance of Fcγ Receptors on Monocytes toward the Inhibitory FcγRIIB in Patients with Chronic ITP.

Helicobater Pylori Infection and Clinical Response to Eradication Therapy in Patients with Immune Thrombocytopenic Purpura (ITP).

The Clinical Efficacy of Helicobacter pylori Eradication in Patients with Helicobacter pylori -Positive Chronic Thrombocytopenic Purpura.

Pegylated Liposomal Doxorubicin (Doxil ® ), Dexamethasone and Low Dose Thalidomide (DDt) as Therapy for Newly Diagnosed Multiple Myeloma.

Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) Results in a High Response Rate in Patients with Refractory Multiple Myeloma (RMM).

Therapeutic Action of Helicobacter pylori ( H. pylori ) Eradication in Patients with Chronic ITP - Lessons from Eradication Therapy on H. pylori -Negative Patients.

Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) a Phase I/II Trial in Advanced Relapsed/Refractory Multiple Myeloma (RMM) Patients.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only